It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Moderate to Severe Overactive Bladder Study

Clinical Trial Title: 
Study for the Treatment of Moderate to Severe Overactive Bladder with Urgency and Incontinence
Clinical Trial Protocol ID: 
11052002
Clinical Trial Investigator Name: 
Barbara Soltes, MD
Clinical Trial Protocol Description: 

This is a study for men and women with moderate to severe urinary urge incontinence with symptoms for greater than six months.

Treatment is for 12 weeks with a medication that is currently approved for use in this indication and is comparing efficacy between two doses of the medication and placebo.

There are three clinic visits and two telephone contacts.

Clinical Trial Eligibility Criteria: 

You may be eligible to participate in this study if you:

  • Are 18 years old or greater
  • Have symptoms of overactive bladder for more than six months
  • Have a urinary frequency (using restroom) eight or more times per 24 hours
  • Have occasions of incontinence (leaking)

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Kidney and Urinary System Disorders
Contact Phone: 
(312) 563-2611
Contact Name: 
Carol Miller